Benefit-Cost Analysis of Voyageurs National Park
In: Evaluation review: a journal of applied social research, Band 4, Heft 6, S. 715-738
ISSN: 0193-841X, 0164-0259
77 Ergebnisse
Sortierung:
In: Evaluation review: a journal of applied social research, Band 4, Heft 6, S. 715-738
ISSN: 0193-841X, 0164-0259
Futures for a Declining City: Simulations for the Cleveland Area discusses the processes associated with decrease in urban population or "urban decline" and other measures of urban size or function. This book describes the case study that analyzes what will happen to a declining metropolitan area and its central city if current trends on urban decline continue, and how that outcome might be affected by various policies designed to counteract further loss. This case study focuses on the Cleveland Standard Metropolitan Statistical Area (SMSA) and its central city, Cleveland. The likely future co
In: The Economic Journal, Band 97, Heft 387, S. 788
In: Journal of policy analysis and management: the journal of the Association for Public Policy Analysis and Management, Band 6, Heft 4, S. 612, 625
ISSN: 0276-8739
In: The journal of development studies: JDS, Band 30, Heft 2, S. 513-514
ISSN: 0022-0388
In: Journal of leisure research: JLR, Band 13, Heft 3, S. 219-231
ISSN: 2159-6417
In: ULTRAS-D-21-00620
SSRN
In: Routledge Revivals
Cover -- Title -- Copyright -- Preface -- Contents -- "A Review History of British Regional Policy -- "Notes on a National Urban Development Strategy for the United States: Politics and Analytics" -- "The National System of Cities as an Object of Public Policy" -- "Optimality in City Size, Systems of Cities and Urban Policy: A Sceptics View" -- "The Agglomeration Process in Urban Growth" -- "Welfare Aspects of National Policy Toward City Sizes" -- "The Pure Theory of City Size in an Industrial Economy
International audience ; This chapter provides a review, derived from the extended survey conducted within the APPRAISAL project, of the integrated assessment methodologies used in different countries to design air quality plans and to estimate the effects of emission abatement policy options on human health. The final purpose of this review is to foster the dissemination of knowledge on integrated assessment for air quality planning at regional and local scales, and to provide policy makers and regulatory bodies across EU member states with a broader understanding of the underlying scientific concepts.
BASE
International audience ; This chapter provides a review, derived from the extended survey conducted within the APPRAISAL project, of the integrated assessment methodologies used in different countries to design air quality plans and to estimate the effects of emission abatement policy options on human health. The final purpose of this review is to foster the dissemination of knowledge on integrated assessment for air quality planning at regional and local scales, and to provide policy makers and regulatory bodies across EU member states with a broader understanding of the underlying scientific concepts.
BASE
In: Environmental management: an international journal for decision makers, scientists, and environmental auditors, Band 21, Heft 2, S. 259-268
ISSN: 1432-1009
Background: Surgery is the main modality of cure for solid cancers and was prioritised to continue during COVID-19 outbreaks. This study aimed to identify immediate areas for system strengthening by comparing the delivery of elective cancer surgery during the COVID-19 pandemic in periods of lockdown versus light restriction. Methods: This international, prospective, cohort study enrolled 20 006 adult (≥18 years) patients from 466 hospitals in 61 countries with 15 cancer types, who had a decision for curative surgery during the COVID-19 pandemic and were followed up until the point of surgery or cessation of follow-up (Aug 31, 2020). Average national Oxford COVID-19 Stringency Index scores were calculated to define the government response to COVID-19 for each patient for the period they awaited surgery, and classified into light restrictions (index 60). The primary outcome was the non-operation rate (defined as the proportion of patients who did not undergo planned surgery). Cox proportional-hazards regression models were used to explore the associations between lockdowns and non-operation. Intervals from diagnosis to surgery were compared across COVID-19 government response index groups. This study was registered at ClinicalTrials.gov, NCT04384926. Findings: Of eligible patients awaiting surgery, 2003 (10·0%) of 20 006 did not receive surgery after a median follow-up of 23 weeks (IQR 16-30), all of whom had a COVID-19-related reason given for non-operation. Light restrictions were associated with a 0·6% non-operation rate (26 of 4521), moderate lockdowns with a 5·5% rate (201 of 3646; adjusted hazard ratio [HR] 0·81, 95% CI 0·77-0·84; p<0·0001), and full lockdowns with a 15·0% rate (1775 of 11 827; HR 0·51, 0·50-0·53; p<0·0001). In sensitivity analyses, including adjustment for SARS-CoV-2 case notification rates, moderate lockdowns (HR 0·84, 95% CI 0·80-0·88; p<0·001), and full lockdowns (0·57, 0·54-0·60; p<0·001), remained independently associated with non-operation. Surgery beyond 12 weeks from diagnosis in patients without neoadjuvant therapy increased during lockdowns (374 [9·1%] of 4521 in light restrictions, 317 [10·4%] of 3646 in moderate lockdowns, 2001 [23·8%] of 11 827 in full lockdowns), although there were no differences in resectability rates observed with longer delays. Interpretation: Cancer surgery systems worldwide were fragile to lockdowns, with one in seven patients who were in regions with full lockdowns not undergoing planned surgery and experiencing longer preoperative delays. Although short-term oncological outcomes were not compromised in those selected for surgery, delays and non-operations might lead to long-term reductions in survival. During current and future periods of societal restriction, the resilience of elective surgery systems requires strengthening, which might include protected elective surgical pathways and long-term investment in surge capacity for acute care during public health emergencies to protect elective staff and services.
BASE
Background Surgery is the main modality of cure for solid cancers and was prioritised to continue during COVID-19 outbreaks. This study aimed to identify immediate areas for system strengthening by comparing the delivery of elective cancer surgery during the COVID-19 pandemic in periods of lockdown versus light restriction. Methods This international, prospective, cohort study enrolled 20 006 adult (≥18 years) patients from 466 hospitals in 61 countries with 15 cancer types, who had a decision for curative surgery during the COVID-19 pandemic and were followed up until the point of surgery or cessation of follow-up (Aug 31, 2020). Average national Oxford COVID-19 Stringency Index scores were calculated to define the government response to COVID-19 for each patient for the period they awaited surgery, and classified into light restrictions (index 60). The primary outcome was the non-operation rate (defined as the proportion of patients who did not undergo planned surgery). Cox proportional-hazards regression models were used to explore the associations between lockdowns and non-operation. Intervals from diagnosis to surgery were compared across COVID-19 government response index groups. This study was registered at ClinicalTrials.gov, NCT04384926. Findings Of eligible patients awaiting surgery, 2003 (10·0%) of 20 006 did not receive surgery after a median follow-up of 23 weeks (IQR 16–30), all of whom had a COVID-19-related reason given for non-operation. Light restrictions were associated with a 0·6% non-operation rate (26 of 4521), moderate lockdowns with a 5·5% rate (201 of 3646; adjusted hazard ratio [HR] 0·81, 95% CI 0·77–0·84; p<0·0001), and full lockdowns with a 15·0% rate (1775 of 11 827; HR 0·51, 0·50–0·53; p<0·0001). In sensitivity analyses, including adjustment for SARS-CoV-2 case notification rates, moderate lockdowns (HR 0·84, 95% CI 0·80–0·88; p<0·001), and full lockdowns (0·57, 0·54–0·60; p<0·001), remained independently associated with non-operation. Surgery beyond 12 weeks from diagnosis in patients without neoadjuvant therapy increased during lockdowns (374 [9·1%] of 4521 in light restrictions, 317 [10·4%] of 3646 in moderate lockdowns, 2001 [23·8%] of 11 827 in full lockdowns), although there were no differences in resectability rates observed with longer delays. Interpretation Cancer surgery systems worldwide were fragile to lockdowns, with one in seven patients who were in regions with full lockdowns not undergoing planned surgery and experiencing longer preoperative delays. Although short-term oncological outcomes were not compromised in those selected for surgery, delays and non-operations might lead to long-term reductions in survival. During current and future periods of societal restriction, the resilience of elective surgery systems requires strengthening, which might include protected elective surgical pathways and long-term investment in surge capacity for acute care during public health emergencies to protect elective staff and services. Funding National Institute for Health Research Global Health Research Unit, Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, Medtronic, Sarcoma UK, The Urology Foundation, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research.
BASE